Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Lee

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Drugs|March 1, 2021
Berotralstat: First ApprovalArnold Lee
Drugs|January 18, 2026
Zongertinib: First ApprovalArnold Lee
Drugs|June 12, 2021
Fuzuloparib: First ApprovalArnold Lee
Targeted Oncology|November 10, 2021
Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian CancerArnold Lee
Drugs|June 3, 2023
Correction to: Nadofaragene Firadenovec: First ApprovalArnold Lee
Drugs|June 27, 2025
Fitusiran: First ApprovalArnold Lee
Hand Clinics|November 28, 2015
Surgical Treatment of Upper Extremity PainArnold Lee Dellon
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 19, 2020
PF-06410293: An Adalimumab BiosimilarArnold Lee, Matt Shirley
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|November 21, 2022
mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisationCaroline Fenton, Arnold Lee
Drugs|July 1, 2021
Remimazolam: A Review in Procedural SedationArnold Lee, Matt Shirley
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Drugs|March 1, 2021
Berotralstat: First ApprovalArnold Lee
Drugs|January 18, 2026
Zongertinib: First ApprovalArnold Lee
Drugs|June 12, 2021
Fuzuloparib: First ApprovalArnold Lee
Targeted Oncology|November 10, 2021
Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian CancerArnold Lee
Drugs|June 3, 2023
Correction to: Nadofaragene Firadenovec: First ApprovalArnold Lee
Drugs|June 27, 2025
Fitusiran: First ApprovalArnold Lee
Hand Clinics|November 28, 2015
Surgical Treatment of Upper Extremity PainArnold Lee Dellon
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 19, 2020
PF-06410293: An Adalimumab BiosimilarArnold Lee, Matt Shirley
Drugs & Therapy Perspectives : for Rational Drug Selection and Use|November 21, 2022
mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisationCaroline Fenton, Arnold Lee
Drugs|July 1, 2021
Remimazolam: A Review in Procedural SedationArnold Lee, Matt Shirley
Pageof 10